These findings indicate that EGFR can be regulated by specific transcription factors, metabolites, kinases, and plant extracts to inhibit tumor cell proliferation, migration, and invasion by blocking downstream signals, thereby making it an important target for the precise treatment of breast cancer. The gene discussed is EGFR; the disease is breast carcinoma.